Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

NCT01518153 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Objectives not met.

Conditions

Leukemia
Lymphoma
Myeloma
Myeloproliferative Diseases

Interventions

DRUG: Fludarabine
DRUG: Melphalan
DRUG: Alemtuzumab
PROCEDURE: Stem Cell Infusion
DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: G-CSF
PROCEDURE: Low Dose Donor T-Cells
PROCEDURE: High Dose Donor T-Cells

Sponsor

M.D. Anderson Cancer Center